Stockreport

Morphic Appoints Dr. Simon Cooper as Chief Medical Officer [Yahoo! Finance]

Keros Therapeutics, Inc. - common stock  (KROS) 
PDF WALTHAM, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapie [Read more]